Calcium/calmodulin-dependent kinase II and Alzheimer's disease

scientific article

Calcium/calmodulin-dependent kinase II and Alzheimer's disease is …
instance of (P31):
scholarly articleQ13442814
review articleQ7318358

External links are
P6179Dimensions Publication ID1027732343
P356DOI10.1186/S13041-015-0166-2
P3181OpenCitations bibliographic resource ID4088814
P932PMC publication ID4657223
P698PubMed publication ID26603284
P5875ResearchGate publication ID284563358

P50authorKarl Peter GieseQ51007195
P2093author name stringAnshua Ghosh
P2860cites workDifferences in the pattern of hippocampal neuronal loss in normal ageing and Alzheimer's diseaseQ57132920
Calmodulin kinase II in pure cultured astrocytesQ69814656
Calcium/calmodulin-dependent protein kinase II phosphorylates tau at Ser-262 but only partially inhibits its binding to microtubulesQ71171772
Phosphorylated mitogen-activated protein kinase (MAPK/ERK-P), protein kinase of 38 kDa (p38-P), stress-activated protein kinase (SAPK/JNK-P), and calcium/calmodulin-dependent kinase II (CaM kinase II) are differentially expressed in tau deposits inQ77544092
Plasticity in the human central nervous systemQ22337156
Amyloid plaque core protein in Alzheimer disease and Down syndromeQ24568384
Amyloid-beta protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memoryQ24645499
Cloning and sequencing of the cDNA encoding a core protein of the paired helical filament of Alzheimer disease: identification as the microtubule-associated protein tauQ24648590
Soluble oligomers of amyloid Beta protein facilitate hippocampal long-term depression by disrupting neuronal glutamate uptakeQ24656613
Activation of CaMKII in single dendritic spines during long-term potentiationQ24658061
Distinct roles of multiple isoforms of CaMKII in signaling to the nucleusQ26823646
Neuropathological stageing of Alzheimer-related changesQ27860862
The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeuticsQ27860914
Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation in vivoQ28131779
Hippocampal synaptic plasticity involves competition between Ca2+/calmodulin-dependent protein kinase II and postsynaptic density 95 for binding to the NR2A subunit of the NMDA receptorQ28202320
alphaCaMKII autophosphorylation: a fast track to memoryQ28249015
Autophosphorylation at Thr286 of the alpha calcium-calmodulin kinase II in LTP and learningQ28260712
Phosphorylation of tau at both Thr 231 and Ser 262 is required for maximal inhibition of its binding to microtubulesQ28282209
New phosphorylation sites identified in hyperphosphorylated tau (paired helical filament-tau) from Alzheimer's disease brain using nanoelectrospray mass spectrometryQ28290064
Selective regulation of neurite extension and synapse formation by the beta but not the alpha isoform of CaMKIIQ28571729
Physical basis of cognitive alterations in alzheimer's disease: Synapse loss is the major correlate of cognitive impairmentQ29547294
Diffusible, nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotoxinsQ29547593
Alzheimer's disease: Initial report of the purification and characterization of a novel cerebrovascular amyloid proteinQ29547803
Abnormal phosphorylation of the microtubule-associated protein tau (tau) in Alzheimer cytoskeletal pathologyQ29617284
Microtubule-associated protein tau (tau) is a major antigenic component of paired helical filaments in Alzheimer diseaseQ29617285
Amyloid deposition as the central event in the aetiology of Alzheimer's diseaseQ29619450
Spatial training preserves associative memory capacity with augmentation of dendrite ramification and spine generation in Tg2576 miceQ30633001
Altered neuronal gene expression in brain regions differentially affected by Alzheimer's disease: a reference data set.Q31146509
Synaptic targeting by Alzheimer's-related amyloid beta oligomers.Q33288786
Dysregulated phosphorylation of Ca(2+) /calmodulin-dependent protein kinase II-α in the hippocampus of subjects with mild cognitive impairment and Alzheimer's diseaseQ33615147
Phosphorylation of Alzheimer disease amyloid precursor peptide by protein kinase C and Ca2+/calmodulin-dependent protein kinase II.Q33642350
Calcium signaling and amyloid toxicity in Alzheimer diseaseQ33799937
A developmental switch in the signaling cascades for LTP inductionQ33962983
L-type voltage-gated calcium channel blockade with isradipine as a therapeutic strategy for Alzheimer's diseaseQ34135977
Structure of the autoinhibited kinase domain of CaMKII and SAXS analysis of the holoenzymeQ34472571
Properties of contextual memory formed in the absence of αCaMKII autophosphorylationQ34573770
Calcium dyshomeostasis and intracellular signalling in Alzheimer's diseaseQ34988301
Neurotrophins enhance CaMKII activity and rescue amyloid-β-induced deficits in hippocampal synaptic plasticityQ35073796
Neuronal Ca2+/calmodulin-dependent protein kinasesQ35231384
Kinases and phosphatases and tau sites involved in Alzheimer neurofibrillary degenerationQ35327851
Mechanism for long-term memory formation when synaptic strengthening is impaired.Q35546780
η-Secretase processing of APP inhibits neuronal activity in the hippocampusQ35760228
Calcium/calmodulin-dependent protein kinase II (CaMKII) inhibition induces neurotoxicity via dysregulation of glutamate/calcium signaling and hyperexcitabilityQ35868150
A Temporary Gating of Actin Remodeling during Synaptic Plasticity Consists of the Interplay between the Kinase and Structural Functions of CaMKIIQ35992894
Single App knock-in mouse models of Alzheimer's disease.Q50670713
Soluble Abeta inhibits specific signal transduction cascades common to the insulin receptor pathway.Q51794745
Immunostaining of calmodulin and aluminium in Alzheimer's disease-affected brains.Q53243202
The expression of calcium/calmodulin-dependent protein kinase II-alpha in the hippocampus of patients with Alzheimer's disease and its links with AD-related pathology.Q53266380
Calcium/calmodulin-dependent protein kinase II immunostaining is preserved in Alzheimer's disease hippocampal neurons.Q53313495
Naringin Enhances CaMKII Activity and Improves Long-Term Memory in a Mouse Model of Alzheimer's DiseaseQ36790422
Neuronal calcium mishandling and the pathogenesis of Alzheimer's diseaseQ36934762
Amyloid flirting with synaptic failure: towards a comprehensive view of Alzheimer's disease pathogenesis.Q37123855
{beta}-Amyloid impairs AMPA receptor trafficking and function by reducing Ca2+/calmodulin-dependent protein kinase II synaptic distributionQ37155459
Localization of alpha type II calcium calmodulin-dependent protein kinase at glutamatergic but not gamma-aminobutyric acid (GABAergic) synapses in thalamus and cerebral cortexQ37502868
The roles of CaMKII and F-actin in the structural plasticity of dendritic spines: a potential molecular identity of a synaptic tag?Q37649267
Novel insights into CaMKII function and regulation during memory formation.Q37808784
CaMKII: claiming center stage in postsynaptic function and organizationQ38181739
Altered calmodulin degradation and signaling in non-neuronal cells from Alzheimer's disease patients.Q39449684
beta-Amyloid peptides destabilize calcium homeostasis and render human cortical neurons vulnerable to excitotoxicityQ41089179
Phosphorylation of microtubule-associated protein tau: identification of the site for Ca2(+)-calmodulin dependent kinase and relationship with tau phosphorylation in Alzheimer tangles.Q41229492
Retrieval of the Alzheimer's amyloid precursor protein from the endosome to the TGN is S655 phosphorylation state-dependent and retromer-mediatedQ41381112
Tau protein becomes long and stiff upon phosphorylation: correlation between paracrystalline structure and degree of phosphorylationQ41588964
Expression and phosphorylation of delta-CaM kinase II in cultured Alzheimer fibroblastsQ42466239
CaMKII and CaMKIV mediate distinct prosurvival signaling pathways in response to depolarization in neurons.Q42611589
APP processing is regulated by cytoplasmic phosphorylationQ42917696
The alterations of Ca2+/calmodulin/CaMKII/CaV1.2 signaling in experimental models of Alzheimer's disease and vascular dementia.Q43548494
Phosphorylation-induced structural changes in the amyloid precursor protein cytoplasmic tail detected by NMR.Q43556227
In situ hybridization of calcium/calmodulin dependent protein kinase II and tau mRNAs: species differences and relative preservation in Alzheimer's diseaseQ43726718
Lack of PSD-95 drives hippocampal neuronal cell death through activation of an alpha CaMKII transduction pathwayQ44173419
Quantitative assessment of cortical synaptic density in Alzheimer's disease.Q44558369
Phosphorylation of tau protein to sites found in Alzheimer's disease brain is catalyzed by Ca2+/calmodulin-dependent protein kinase II as demonstrated tandem mass spectrometryQ44686316
Modulation of calcium/calmodulin kinase-II provides partial neuroprotection against beta-amyloid peptide toxicityQ44847913
Excitotoxic activation of the NMDA receptor results in inhibition of calcium/calmodulin kinase II activity in cultured hippocampal neurons.Q45083445
Dendrite and dendritic spine alterations in Alzheimer modelsQ45099584
Autonomous activity of CaMKII is only transiently increased following the induction of long-term potentiation in the rat hippocampus.Q45173071
Hippocampal neurons predisposed to neurofibrillary tangle formation are enriched in type II calcium/calmodulin-dependent protein kinaseQ45273785
βCaMKII plays a nonenzymatic role in hippocampal synaptic plasticity and learning by targeting αCaMKII to synapses.Q45786919
Phosphorylation of tau proteins to a state like that in Alzheimer's brain is catalyzed by a calcium/calmodulin-dependent kinase and modulated by phospholipids.Q45976976
Attenuation of beta-amyloid neurotoxicity in vitro by potassium-induced depolarizationQ46198723
Phosphorylation of tau at serine 416 by Ca2+/calmodulin-dependent protein kinase II in neuronal soma in brainQ46586214
Amyloid beta prevents activation of calcium/calmodulin-dependent protein kinase II and AMPA receptor phosphorylation during hippocampal long-term potentiationQ46641415
Differential regulation of brain-derived neurotrophic factor and type II calcium/calmodulin-dependent protein kinase messenger RNA expression in Alzheimer's diseaseQ46642796
Reduction of NR1 and phosphorylated Ca2+/calmodulin-dependent protein kinase II levels in Alzheimer's diseaseQ46764167
Quantitative synaptic alterations in the human neocortex during normal agingQ46773797
NMDA receptor-dependent long-term potentiation in mouse hippocampal interneurons shows a unique dependence on Ca(2+)/calmodulin-dependent kinasesQ46989427
Synaptic alterations in CA1 in mild Alzheimer disease and mild cognitive impairment.Q48182788
Handling and environmental enrichment do not rescue learning and memory impairments in alphaCamKII(T286A) mutant miceQ48220792
Phosphorylated tau protein is integrated into paired helical filaments in Alzheimer's diseaseQ48341418
Selective loss of synaptic proteins in Alzheimer's disease: evidence for an increased severity with APOE varepsilon4.Q48482230
Autophosphorylation of alphaCaMKII is not a general requirement for NMDA receptor-dependent LTP in the adult mouseQ48521560
Kinase-dead knock-in mouse reveals an essential role of kinase activity of Ca2+/calmodulin-dependent protein kinase IIalpha in dendritic spine enlargement, long-term potentiation, and learning.Q48577304
Alzheimer's disease and Down's syndrome: Sharing of a unique cerebrovascular amyloid fibril proteinQ48634030
An English translation of Alzheimer's 1907 paper, "Uber eine eigenartige Erkankung der Hirnrinde".Q48903618
alpha-calcium-calmodulin-dependent kinase II is associated with paired helical filaments of Alzheimer's diseaseQ48934721
Synapse loss in frontal cortex biopsies in Alzheimer's disease: correlation with cognitive severityQ48983820
P275copyright licenseCreative Commons Attribution 4.0 InternationalQ20007257
P6216copyright statuscopyrightedQ50423863
P433issue1
P407language of work or nameEnglishQ1860
P921main subjectenzymeQ8047
peptideQ172847
Alzheimer's diseaseQ11081
Ca2+/calmodulin-dependent protein kinaseQ26261927
P5008on focus list of Wikimedia projectScienceSourceQ55439927
P304page(s)78
P577publication date2015-11-24
P1433published inMolecular BrainQ6895938
P1476titleCalcium/calmodulin-dependent kinase II and Alzheimer's disease
P478volume8

Reverse relations

cites work (P2860)
Q64054584A Comprehensive Analysis of the CaMK2A Gene and Susceptibility to Alzheimer's Disease in the Han Chinese Population
Q54963859A homozygous loss-of-function CAMK2A mutation causes growth delay, frequent seizures and severe intellectual disability.
Q47141209A meta-analysis of cerebrospinal fluid visinin-like protein-1 in alzheimers disease patients relative to healthy controls and mild cognitive impairment patients
Q50420723AD-Related N-Terminal Truncated Tau Is Sufficient to Recapitulate In Vivo the Early Perturbations of Human Neuropathology: Implications for Immunotherapy
Q93273205Alzheimer's Disease: A short introduction to the calmodulin hypothesis
Q96431918Alzheimer's disease-related dysregulation of mRNA translation causes key pathological features with ageing
Q27303472Alzheimer-related decrease in CYFIP2 links amyloid production to tau hyperphosphorylation and memory loss
Q64880227Alzheimer’s Disease Associated Genes Ankyrin and Tau Cause Shortened Lifespan and Memory Loss in Drosophila.
Q47587356Ca2+/calmodulin-dependent protein kinase II promotes neurodegeneration caused by tau phosphorylated at Ser262/356 in a transgenic Drosophila model of tauopathy
Q33899308CaMK II γ down regulation protects dorsal root ganglion neurons from ropivacaine hydrochloride neurotoxicity
Q57524986CaMKII Metaplasticity Drives Aβ Oligomer-Mediated Synaptotoxicity
Q41105294Characterization of postsynaptic calcium signals in the pyramidal neurons of anterior cingulate cortex.
Q41279397Chronic diabetic states worsen Alzheimer neuropathology and cognitive deficits accompanying disruption of calcium signaling in leptin-deficient APP/PS1 mice
Q38958106Dysregulation of neuronal calcium homeostasis in Alzheimer's disease - A therapeutic opportunity?
Q47393215Enhanced Peptide Detection Toward Single-Neuron Proteomics by Reversed-Phase Fractionation Capillary Electrophoresis Mass Spectrometry
Q47704920In vitro neurotoxicity by ropivacaine is reduced by silencing Cav3.3 T-type calcium subunits in neonatal rat sensory neurons
Q64998890Involvement of calpain in the neuropathogenesis of Alzheimer's disease.
Q90706367Low Phytanic Acid-Concentrated DHA Prevents Cognitive Deficit and Regulates Alzheimer Disease Mediators in an ApoE-/- Mice Experimental Model
Q41928616Memory Erasure Experiments Indicate a Critical Role of CaMKII in Memory Storage
Q38962796Mitochondrial Dysfunction and Synaptic Transmission Failure in Alzheimer's Disease
Q60689081Modulation of serine/threonine phosphatases by melatonin: therapeutic approaches in neurodegenerative diseases
Q92281827Neuromodulatory Action of Picomolar Extracellular Aβ42 Oligomers on Presynaptic and Postsynaptic Mechanisms Underlying Synaptic Function and Memory
Q58727014Postsynaptic Proteome of Non-Demented Individuals with Alzheimer's Disease Neuropathology
Q57492342Potential Effects of MSC-Derived Exosomes in Neuroplasticity in Alzheimer's Disease
Q59812522Prolyl Isomerase Pin1 Directly Regulates Calcium/Calmodulin-Dependent Protein Kinase II Activity in Mouse Brains
Q61443149S-nitrosylation of E3 ubiquitin-protein ligase RNF213 alters non-canonical Wnt/Ca+2 signaling in the P301S mouse model of tauopathy
Q91952785Tau underlies synaptic and cognitive deficits for type 1, but not type 2 diabetes mouse models
Q52310268VariFunNet, an integrated multiscale modeling framework to study the effects of rare non-coding variants in Genome-Wide Association Studies: applied to Alzheimer's Disease.

Search more.